Healthcare providers should take steps now to ensure that the telehealth modalities they use are HIPAA compliant.
An analysis of data from the NIH-AARP Diet and Health Study evaluated the association between consumption of various foods and the development of MPN.
The recommendation was made based on the number of confirmed COVID-19 cases among these 2 groups, as well as ethical and scientific considerations.
Most study authors at the 2019 Society of Gynecologic Oncology Annual Meeting failed to disclose industry relationships, a study found.
The management of AL amyloidosis and immunoglobulin disease during the COVID-19 pandemic should be individualized based on several patient-specific aspects.
This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
An evaluation of more than 2 dozen types of integrative medicine therapies demonstrated that patients with MPNs who engaged in these activities had improved negative symptoms and quality of life.
Researchers devised a comprehensive diagnostic approach to evaluating severe reactive hemophagocytic lymphohistiocytosis.
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
A new meta-analysis indicates that the true prevalence of pulmonary hypertension linked to myeloproliferative neoplasms is not well understood.
A small, single-arm, phase 2 study results demonstrate efficacy and safety of this combination therapy in patients with MPN-AP or MPN-BP.
Investigators summarized current literature surrounding the diagnosis and risk-stratification of PV and ET, and reviewed available and upcoming therapies.
The trial will continue as planned and final analysis is expected when the number of confirmed COVID-19 cases reaches 164.
The use of patient-reported outcome measures specific to GD1 appears to capture health-related quality of life related issues that may otherwise be missed.
Some pointers from a review of assessment and management strategies for nurses caring for patients with polycythemia vera.
Researchers sought to determine the benefits of longer-term therapeutics for patients with cancer.
The British Society of Hematology has updated their guidelines on the use of irradiated blood components.
Using validated tools, investigators determined that patients with a MPN were likely to experience significant symptoms of depression.
The application is supported by data from the double-blind, placebo-controlled phase 3 VOYAGER PAD trial.
As part of the Zero Childhood Cancer Program, high-risk pediatric tumors were characterized by whole-genome sequencing, RNA sequencing, and methylation profiling.
Use of the algorithm could lead to improved use of supportive care.
Research presented at ASCO Quality Care Symposium revealed a need for better education regarding geriatric assessment tools among oncology clinicians.
Elective cancer surgery within COVID-19–free surgical pathways results in lower pulmonary complication, SARS-CoV-2 infection, and mortality rates.
Clinical trials leading to US FDA approvals of anticancer therapies continue to underrepresent women.
AL amyloidosis patients with hematologic response and low serum free light chain levels may have longer OS.
The FDA and EMA expressed the need for trial sponsors to coordinate their submissions of initial pediatric study plans and pediatric investigation plans for new oncology drugs.
Patients with severe COVID-19 may benefit from a fixed-dose or shock-dependent dosing of hydrocortisone, but early study termination hindered definitive conclusions.
An analysis showed that outcomes of SARS-CoV-2 infections can be disproportionately mild in some patient cohorts.
In the CRL, the FDA recommended that the Company conduct at least 1 additional randomized, clinical study.
Interferon-alpha and pegylated interferon-alpha, as well as hydroxyurea and anagrelide, represent cytoreductive approaches to the treatment of patients with ET and PV.
Antibody testing after the early stages of the SARS-CoV-2 pandemic has significantly increased in the proportion of first-time blood donors.
Researchers determined whether machine learning could predict stem cell transplant response in severe scleroderma.
Researchers conducted a retrospective cohort analysis to assess the prevalence and effects of inappropriate empirical antibiotic therapy for bloodstream infections.
While several studies have investigated SARS-CoV-2 contamination in health care settings, patterns in oncology clinics with fewer COVID-19 cases is unclear.
Implementing a role especially for helping patients manage their oral chemotherapy improved adherence, AE management, and other challenges patients experience.
The expanded approval was based on data from the pivotal phase 3 COMPACT study and the COMPACT open-label extension study.
Cannabis use was associated with poorer outcomes with immune checkpoint inhibitors among patients with advanced cancers.
The FDA has approved Nucala (mepolizumab; GlaxoSmithKline) for the treatment of hypereosinophilic syndrome (HES) for 6 months or longer without another identifiable non-blood related cause of the disease in patients aged 12 years and older.
Researchers evaluated an approach to treatment guided by histopathologic subtype in patients with idiopathic multicentric Castleman disease.
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
Patients in Ireland logged shorter hospital stays and had fewer emergency department visits during the COVID-19 pandemic.
Germline polymorphisms can affect response to treatment in people with polycythemia vera.
Tenapanor is a first-in-class oral medication that works by blocking the NHE3 transporter in the gastrointestinal tract.
Avacopan is an orally-administered, small molecule designed to selectively block the complement 5a receptor on destructive inflammatory cells such as blood neutrophils.
How to explain adjustments to cancer care due to the COVID-19 pandemic and ease patients’ fears about the impact of those changes.
Practices need to know all of the components of their health information systems to determine potential vulnerabilities.
Engineered cytokine evades the tumor’s defenses and boosts the production of stem-like polyfunctional T cells.
Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.
Although most parents of children with cancer form trusting relationships with their children’s oncologists, poor outcomes may negatively affect this.